Navigation Links
PharmaVentures Appoints Paul Phull as Senior Director
Date:8/30/2010

PharmaVentures Appoints Paul Phull as Senior Director -- OXFORD, England, August 31, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, Personnel Announcements Click to view news release full screen  

PharmaVentures Appoints Paul Phull as Senior Director

 

OXFORD, England, August 31, 2010 /PRNewswire/ --

- New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory Services to its Clients

PharmaVentures Ltd (http://www.pharmaventures.com) ("PharmaVentures") today announced that Paul Phull has joined the company as Senior Director. With more than 24 years of senior level commercial, business/corporate development and general management experience in the pharmaceutical, biotechnology and medical device industries, Paul will be responsible for developing PharmaVentures' Corporate Advisory business.

Paul joins PharmaVentures from Sinclair Pharma plc, a UK listed specialty pharmaceutical company, where he was responsible for the development of the international business with a marketing partner network spanning over 80 countries. He was also responsible for corporate development and worked on the acquisition and integration of European sales and marketing companies in France, Spain and Italy into the Sinclair group. Paul has significant deal making and corporate transaction experience with a broad range and size of companies in Europe, USA, Japan, India and Asia in a number of therapeutic areas.

"I am very pleased to welcome Paul to PharmaVentures," said Dr Fintan Walton, Chief Executive Officer. "His strategic approach and industry experience will significantly enhance corporate advisory services, particularly with respect to our transactions offerings."

About PharmaVentures

PharmaVentures Limited (http://www.pharmaventures.com) is based in Oxford, England and is a leading international corporate advisory firm supporting its clients' growth ambitions through licensing, joint ventures and M&A in the healthcare industry. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisors, investment companies and government bodies. It also produces the highly popular PharmaDeals(R) range of intelligence products including analysis tools and reports. In 2006 it launched the world's first dedicated online pharmaceutical television channel PharmaTelevision(R) ( http://www.pharmatelevision.com)

Doug Cookson Commercial Director, PharmaVentures T: +44(0)1865-332731 E: doug.cookson@pharmaventures.com
'/>"/>

SOURCE PharmaVentures
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
2. Jennerex Appoints Lara Longpre to Chief Operating Officer
3. Regenicin Appoints Amgen Co-founder Dr. Joseph Rubinfeld to Board of Directors
4. Fluidnet Corporation Appoints Benjamin E. Bulkley President and Chief Executive Officer
5. Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
6. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
7. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
8. InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
9. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
10. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
11. Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
Breaking Medicine News(10 mins):